Global pharmaceutical company Insmed Incorporated has announced plans to raise USD 500 million via a public offering of its common stock. The underwriters have been granted an option to purchase up to 15% of the shares.
The company does not disclose other details, such as the date of the offering and the specific use of the funds.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.